In summary, a growing body of evidence suggests that the broadness of the anti-MoA memory CD8 + T cell repertoire - built upon the individual experience of interaction with intracellular pathogens and intestinal microbiota - may strongly influence the fate of tumor progression and prognosis. This evidence concerns the gene CD8A and neoplasm.